The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer [vol 45, pg 507, 2022]

被引:1
|
作者
Khatoon, Elina [1 ,2 ]
Hegde, Mangala [1 ,2 ]
Kumar, Aviral [1 ,2 ]
Daimary, Uzini Devi [1 ,2 ]
Sethi, Gautam [3 ,4 ]
Bishayee, Anupam [5 ]
Kunnumakkara, Ajaikumar B. [1 ,2 ]
机构
[1] Indian Inst Technol IIT Guwahati, Dept Biosci & Bioengn, Canc Biol Lab, Gauhati 781039, Assam, India
[2] Indian Inst Technol IIT Guwahati, DBT AIST Int Ctr Translat & Environm Res DAICENTER, Gauhati 781039, Assam, India
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore
[4] Natl Univ Singapore, NUS Ctr Canc Res, Yong Loo Lin Sch Med, Singapore, Singapore
[5] Lake Erie Coll Osteopath Med, Coll Osteopath Med, Bradenton, FL 34211 USA
关键词
D O I
10.1007/s12272-023-01434-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:206 / 206
页数:1
相关论文
共 50 条
  • [21] The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma (vol 16, pg 55, 2018)
    Keller, A.
    Wingelhofer, B.
    Peter, B.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2019, 17 (03) : 446 - 447
  • [22] Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors
    Mancikova, Veronika
    Montero-Conde, Cristina
    Perales-Paton, Javier
    Fernandez, Agustin
    Santacana, Maria
    Jodkowska, Karolina
    Inglada-Perez, Lucia
    Castelblanco, Esmeralda
    Borrego, Salud
    Encinas, Mario
    Matias-Guiu, Xavier
    Fraga, Mario
    Robledo, Mercedes
    CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1334 - 1345
  • [23] Role of CXCR4 in HIV infection and its potential as a therapeutic target (vol 5, pg 1025, 2010)
    Murakami, Tsutomu
    Yamamoto, Naoki
    FUTURE MICROBIOLOGY, 2010, 5 (09) : 1446 - 1446
  • [24] Cytokine signaling through the JAK2/STAT3 pathway is a viable therapeutic target in non-small cell lung cancer
    Looyenga, Brendan D.
    CANCER RESEARCH, 2012, 72
  • [25] The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (vol 30, pg 726, 2022)
    Verma, Ankit
    Pittala, Srinivas
    Alhozeel, Belal
    Shteinfer-Kuzmine, Anna
    Ohana, Ehud
    Gupta, Rajeev
    Chung, Jay H.
    Shoshan-Barmatz, Varda
    MOLECULAR THERAPY, 2024, 32 (04) : 1178 - 1178
  • [26] Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer - the role of STAT3 and p21
    Prabaharan, Chandra Bose
    Yang, Allan Boyao
    Chidambaram, Divya
    Rajamanickam, Karthic
    Napper, Scott
    Sakharkar, Meena Kishore
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 909 - 921
  • [27] Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer – the role of STAT3 and p21
    Chandra Bose Prabaharan
    Allan Boyao Yang
    Divya Chidambaram
    Karthic Rajamanickam
    Scott Napper
    Meena Kishore Sakharkar
    Investigational New Drugs, 2020, 38 : 909 - 921
  • [28] EGCG enhances the therapeutic potential of gemcitabine and CP690550 (Tasocitinib) by inhibiting STAT3 signaling pathway in human pancreatic cancer cells
    Tang, Su-Ni
    Fu, Junsheng
    Shankar, Sharmila
    Srivastava, Rakesh K.
    CANCER RESEARCH, 2012, 72
  • [29] Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway (vol 26, pg 829, 2019)
    Zhang, Tao
    Zhu, Xinying
    Qiu, Jinxia
    Jiang, Kangfeng
    Zhao, Gan
    Wu, Haichong
    Deng, Ganzhen
    Qiu, Changwei
    REPRODUCTIVE SCIENCES, 2021, 28 (02) : 614 - 614
  • [30] The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma (vol 14, pg 5783, 2022)
    Wan, Zhongzhong
    Li, Xingrun
    Luo, Xinru
    Wang, Bofan
    Zhou, Xiang
    Chen, Ao
    AGING-US, 2022, 14 (19): : 8139 - 8139